Morten Møller Poulsen

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. doi request reprint Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine, MEA, Aarhus University Hospital and Institute of Clinical Medicine, Aarhus University, Denmark Electronic address
    Biochim Biophys Acta 1852:1124-36. 2015
  2. doi request reprint Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Tage Hansens Gade 2, 8000 Arhus C, Denmark
    Nutr Res 32:701-8. 2012
  3. pmc High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition
    Morten M Poulsen
    Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
    Diabetes 62:1186-95. 2013
  4. doi request reprint Resveratrol in metabolic health: an overview of the current evidence and perspectives
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine, MEA, Aarhus University Hospital and Institute of Clinical Medicine, Aarhus University, Denmark
    Ann N Y Acad Sci 1290:74-82. 2013
  5. doi request reprint Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
    Thomas Nordstrøm Kjaer
    Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Aarhus C, Denmark
    Prostate 75:1255-63. 2015

Collaborators

  • Bjørn Richelsen
  • Niels Jessen
  • Thomas Nordstrøm Kjaer
  • Arieh Sierra Cohen
  • Jens Otto Lunde Jørgensen
  • Steen Bønløkke Pedersen
  • David Michael Hougaard
  • Shadman Neghabat
  • Marie Juul Ornstrup

Detail Information

Publications5

  1. doi request reprint Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine, MEA, Aarhus University Hospital and Institute of Clinical Medicine, Aarhus University, Denmark Electronic address
    Biochim Biophys Acta 1852:1124-36. 2015
    ..This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes. ..
  2. doi request reprint Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Tage Hansens Gade 2, 8000 Arhus C, Denmark
    Nutr Res 32:701-8. 2012
    ....
  3. pmc High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition
    Morten M Poulsen
    Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
    Diabetes 62:1186-95. 2013
    ..The lack of effect disagrees with persuasive data obtained from rodent models and raises doubt about the justification of resveratrol as a human nutritional supplement in metabolic disorders...
  4. doi request reprint Resveratrol in metabolic health: an overview of the current evidence and perspectives
    Morten Møller Poulsen
    Department of Endocrinology and Internal Medicine, MEA, Aarhus University Hospital and Institute of Clinical Medicine, Aarhus University, Denmark
    Ann N Y Acad Sci 1290:74-82. 2013
    ..In this review, we provide a brief overview of the field and discuss the future scientific directions of resveratrol research. ..
  5. doi request reprint Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
    Thomas Nordstrøm Kjaer
    Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Aarhus C, Denmark
    Prostate 75:1255-63. 2015
    ..So far, no human trials have evaluated the effects of resveratrol on circulating androgens, prostate size, or biochemical markers of prostate size...